Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab

Case Report: Prolonged remission of metastatic cisplatin-refractory nasopharyngeal carcinoma with Pembrolizumab

BackgroundEpstein-Barr virus (EBV)-related nasopharyngeal cancer (NPC) is a common type of cancer in certain areas of the world such as southeast Asia, but is uncommon in Canada. There is currently no reliably effective standard treatment for incurable metastatic EBV-related NPC that progresses afte...

Full description

Bibliographic Details
Main Authors: Wei Cen Wang, Beatrice Preti, Nancy Read, Paul Gibson, Keith Kwan, Eric Winquist
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Oncology
Subjects:
nasopharyngeal carcinoma
PD-1 inhibitor
pembrolizumab
overall survival
progression free survival
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1249453/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1249453/full

Similar Items